Skip to main content
Top
Published in: World Journal of Surgery 5/2008

01-05-2008

Sporadic Paraganglioma

Authors: James A. Lee, Quan-Yang Duh

Published in: World Journal of Surgery | Issue 5/2008

Login to get access

Abstract

Paraganglioma are rare chromaffin cell tumors that develop from the neural crest cells. Parasympathetic ganglia-derived tumors are found almost exclusively in the neck and skull base and typically do not secrete catecholamines. In contrast, most sympathetic ganglia-derived tumors are found in the abdomen and produce an excess of catecholamines. Those grow within the adrenal medulla and are known as pheochromocytoma. Other sympathetic paragangliomas are also known as extra-adrenal pheochromocytomas. They arise outside of the adrenal gland and can be found anywhere along the sympathetic chain from the base of the skull and neck (5% of cases) to the bladder and prostate gland (10%). We use the term paraganglioma to refer to extra-adrenal tumors and pheochromocytoma to refer to intra-adrenal tumors. The majority of sympathetic paragangliomas are familial, commonly associated with the SDHB and SDHD gene mutations. Many are malignant. Medical management of catecholamine-secreting paraganglioma is the same as for pheochromocytoma. Favorably located abdominal paragangliomas can be safely resected laparoscopically, but the operation is technically more challenging than that for adrenalectomy.
Literature
1.
go back to reference Erickson D, Kudva YC, Ebersold MJ, et al. (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86(11):5210–5216PubMedCrossRef Erickson D, Kudva YC, Ebersold MJ, et al. (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86(11):5210–5216PubMedCrossRef
2.
go back to reference Whalen RK, Althausen AF, Daniels GH (1992) Extra-adrenal pheochromocytoma. J Urol 147(1):1–10PubMed Whalen RK, Althausen AF, Daniels GH (1992) Extra-adrenal pheochromocytoma. J Urol 147(1):1–10PubMed
4.
go back to reference Elder EE, Elder G, Larsson C (2005) Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 89(3):193–201PubMedCrossRef Elder EE, Elder G, Larsson C (2005) Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 89(3):193–201PubMedCrossRef
5.
go back to reference Plouin PF, Gimenez-Roqueplo AP (2006) Pheochromocytomas and secreting paragangliomas. Orphanet J Rare Dis 1(1):49PubMedCrossRef Plouin PF, Gimenez-Roqueplo AP (2006) Pheochromocytomas and secreting paragangliomas. Orphanet J Rare Dis 1(1):49PubMedCrossRef
6.
go back to reference Sclafani LM, Woodruff JM, Brennan MF (1990) Extraadrenal retroperitoneal paragangliomas: natural history and response to treatment. Surgery 108(6):1124–1129; discussion 9–30PubMed Sclafani LM, Woodruff JM, Brennan MF (1990) Extraadrenal retroperitoneal paragangliomas: natural history and response to treatment. Surgery 108(6):1124–1129; discussion 9–30PubMed
7.
go back to reference Gifford RW Jr, Manger WM, Bravo EL (1994) Pheochromocytoma. Endocrinol Metab Clin North Am 23(2):387–404PubMed Gifford RW Jr, Manger WM, Bravo EL (1994) Pheochromocytoma. Endocrinol Metab Clin North Am 23(2):387–404PubMed
8.
go back to reference Mantero F, Albiger N (2004) A comprehensive approach to adrenal incidentalomas. Arq Bras Endocrinol Metabol 48(5):583–591PubMed Mantero F, Albiger N (2004) A comprehensive approach to adrenal incidentalomas. Arq Bras Endocrinol Metabol 48(5):583–591PubMed
9.
go back to reference Ogawa J, Inoue H, Koide S, et al. (1982) Functioning paraganglioma in the posterior mediastinum. Ann Thorac Surg 33(5):507–510PubMedCrossRef Ogawa J, Inoue H, Koide S, et al. (1982) Functioning paraganglioma in the posterior mediastinum. Ann Thorac Surg 33(5):507–510PubMedCrossRef
10.
go back to reference Plouin PF, Duclos JM, Menard J, et al. (1981) Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. Br Med J (Clin Res Ed) 282(6267):853–854 Plouin PF, Duclos JM, Menard J, et al. (1981) Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. Br Med J (Clin Res Ed) 282(6267):853–854
11.
12.
go back to reference Bravo EL, Tagle R (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24(4):539–553PubMedCrossRef Bravo EL, Tagle R (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24(4):539–553PubMedCrossRef
13.
go back to reference Bravo EL, Tarazi RC, Gifford RW, et al. (1979) Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med 301(13):682–686PubMedCrossRef Bravo EL, Tarazi RC, Gifford RW, et al. (1979) Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med 301(13):682–686PubMedCrossRef
14.
go back to reference Kudva YC, Sawka AM, Young WF Jr (2003) Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab 88(10):4533–4539PubMedCrossRef Kudva YC, Sawka AM, Young WF Jr (2003) Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab 88(10):4533–4539PubMedCrossRef
15.
go back to reference Sawka AM, Jaeschke R, Singh RJ, et al. (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88(2):553–558PubMedCrossRef Sawka AM, Jaeschke R, Singh RJ, et al. (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88(2):553–558PubMedCrossRef
16.
go back to reference Lenders JW, Eisenhofer G, Armando I, et al. (1993) Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem 39(1):97–103PubMed Lenders JW, Eisenhofer G, Armando I, et al. (1993) Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem 39(1):97–103PubMed
17.
go back to reference Lenders JW, Keiser HR, Goldstein DS, et al. (1995) Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med 123(2):101–109PubMed Lenders JW, Keiser HR, Goldstein DS, et al. (1995) Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med 123(2):101–109PubMed
18.
go back to reference Lee JA Zarnegar R, Shen WT, et al. (2007) Adrenal incidentaloma, borderline elevations of urine or plasma metanephrines and the “subclinical” pheochromocytoma. Arch Surg 142(9):870-873; discussion 73-74CrossRef Lee JA Zarnegar R, Shen WT, et al. (2007) Adrenal incidentaloma, borderline elevations of urine or plasma metanephrines and the “subclinical” pheochromocytoma. Arch Surg 142(9):870-873; discussion 73-74CrossRef
19.
go back to reference Hsiao RJ, Parmer RJ, Takiyyuddin MA, et al. (1991) Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine 70(1):33–45PubMedCrossRef Hsiao RJ, Parmer RJ, Takiyyuddin MA, et al. (1991) Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine 70(1):33–45PubMedCrossRef
20.
go back to reference Young WF Jr (1997) Phaeochromocytoma: how to catch a moonbeam in your hand. Eur J Endocrinol 136(1):28–29PubMedCrossRef Young WF Jr (1997) Phaeochromocytoma: how to catch a moonbeam in your hand. Eur J Endocrinol 136(1):28–29PubMedCrossRef
21.
go back to reference Manger WM, Eisenhofer G (2004) Pheochromocytoma: diagnosis and management update. Curr Hypertens Rep 6(6):477–484PubMedCrossRef Manger WM, Eisenhofer G (2004) Pheochromocytoma: diagnosis and management update. Curr Hypertens Rep 6(6):477–484PubMedCrossRef
22.
go back to reference Pacak K, Eisenhofer G, Ilias I (2004) Diagnostic imaging of pheochromocytoma. Front Horm Res 31:107–120PubMed Pacak K, Eisenhofer G, Ilias I (2004) Diagnostic imaging of pheochromocytoma. Front Horm Res 31:107–120PubMed
23.
go back to reference Quint LE, Glazer GM, Francis IR, et al. (1987) Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology 165(1):89–93PubMed Quint LE, Glazer GM, Francis IR, et al. (1987) Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology 165(1):89–93PubMed
24.
go back to reference Bessell-Browne R, O’Malley ME (2007) CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol 188(4):970–974PubMedCrossRef Bessell-Browne R, O’Malley ME (2007) CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol 188(4):970–974PubMedCrossRef
25.
go back to reference Mukherjee JJ, Peppercorn PD, Reznek RH, et al. (1997) Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 202(1):227–231PubMed Mukherjee JJ, Peppercorn PD, Reznek RH, et al. (1997) Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 202(1):227–231PubMed
26.
go back to reference Francis IR, Korobkin M (1996) Pheochromocytoma. Radiol Clin North Am 4(6):1101–1112 Francis IR, Korobkin M (1996) Pheochromocytoma. Radiol Clin North Am 4(6):1101–1112
27.
go back to reference Honigschnabl S, Gallo S, Niederle B, et al. (2002) How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 41(2):113–122PubMedCrossRef Honigschnabl S, Gallo S, Niederle B, et al. (2002) How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 41(2):113–122PubMedCrossRef
28.
go back to reference Timmers HJ, Kozupa A, Chen CC, et al. (2007) Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25(16):2262–2269PubMedCrossRef Timmers HJ, Kozupa A, Chen CC, et al. (2007) Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25(16):2262–2269PubMedCrossRef
29.
go back to reference Ilias I, Pacak K (2004) Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89(2):479–491PubMedCrossRef Ilias I, Pacak K (2004) Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89(2):479–491PubMedCrossRef
30.
go back to reference Elgazzar AH, Gelfand MJ, Washburn LC, et al. (1995) I-123 MIBG scintigraphy in adults. A report of clinical experience. Clin Nucl Med 20(2):147–152PubMedCrossRef Elgazzar AH, Gelfand MJ, Washburn LC, et al. (1995) I-123 MIBG scintigraphy in adults. A report of clinical experience. Clin Nucl Med 20(2):147–152PubMedCrossRef
31.
go back to reference Pacak K, Eisenhofer G, Ahlman H, et al. (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium, October 2005. Nat Clin Pract Endocrinol Metab 3(2):92–102PubMedCrossRef Pacak K, Eisenhofer G, Ahlman H, et al. (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium, October 2005. Nat Clin Pract Endocrinol Metab 3(2):92–102PubMedCrossRef
32.
go back to reference Grufferman S, Gillman MW, Pasternak LR, et al. (1980) Familial carotid body tumors: case report and epidemiologic review. Cancer 46(9):2116–2122PubMedCrossRef Grufferman S, Gillman MW, Pasternak LR, et al. (1980) Familial carotid body tumors: case report and epidemiologic review. Cancer 46(9):2116–2122PubMedCrossRef
33.
go back to reference Amar L, Bertherat J, Baudin E, et al. (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23(34):8812–8818PubMedCrossRef Amar L, Bertherat J, Baudin E, et al. (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23(34):8812–8818PubMedCrossRef
34.
go back to reference Neumann HP, Bausch B, McWhinney SR, et al. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346(19):1459–1466PubMedCrossRef Neumann HP, Bausch B, McWhinney SR, et al. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346(19):1459–1466PubMedCrossRef
35.
go back to reference Neumann HP, Pawlu C, Peczkowska M, et al. (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292(8):943–951PubMedCrossRef Neumann HP, Pawlu C, Peczkowska M, et al. (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292(8):943–951PubMedCrossRef
Metadata
Title
Sporadic Paraganglioma
Authors
James A. Lee
Quan-Yang Duh
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 5/2008
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9360-4

Other articles of this Issue 5/2008

World Journal of Surgery 5/2008 Go to the issue